The Role of CXCL13 and CXCL9 in Early Breast Cancer-Reference-Cited by-同舟云学术

The Role of CXCL13 and CXCL9 in Early Breast Cancer

Published:2020-02 Issue:1 Volume:20 Page:e36-e53
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Razis Evangelia,Kalogeras Konstantine T.,Kotsantis Ioannis,Koliou Georgia-Angeliki,Manousou Kyriaki,Wirtz Ralph,Veltrup Elke,Patsea Helen,Poulakaki Nikiforita,Dionysopoulos Dimitrios,Pervana Stavroula,Gogas Helen,Koutras Angelos,Pentheroudakis George,Christodoulou Christos,Linardou Helena,Pavlakis Kitty,Koletsa Triantafyllia,Pectasides Dimitrios,Zagouri Flora,Fountzilas George

Funder

Hellenic Cooperative Oncology Group

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference34 articles.

1. The chemokine system in cancer biology and therapy;Mantovani;Cytokine Growth Factor Rev,2010

2. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy;Nagarsheth;Nat Rev Immunol,2017

3. Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression;Razis;Clin Breast Cancer,2012

4. CXCL13/CXCR5 signaling enhances BCR-triggered B-cell activation by shaping cell dynamics;Saez de Guinoa;Blood,2011

5. CXCR3 in T cell function;Groom;Exp Cell Res,2011

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Senomorphic activity of a combination of niacinamide and hyaluronic acid: correlation with clinical improvement of skin aging;Scientific Reports;2024-07-15

2. Quantifying spatial CXCL9 distribution with image analysis predicts improved prognosis of triple-negative breast cancer;Frontiers in Genetics;2024-06-18

3. Advances in the study of tertiary lymphoid structures in the immunotherapy of breast cancer;Frontiers in Oncology;2024-04-02

4. Transcriptome analysis reveals the clinical significance of CXCL13 in Pan-Gyn tumors;Journal of Cancer Research and Clinical Oncology;2024-03-09

5. Gene expression alterations predict the pathological complete response in triple-negative breast cancer exploratory analysis of the NACATRINE trial;Scientific Reports;2023-12-04